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MicroCTIntroduction: The assessment of thrombus size following treatments directed at preventing thrombosis or en-
hancing its resolution has generally relied on physical or histological methods. This cross-sectional design im-
poses the need for increased numbers of animals for experiments. Micro-computed tomography (microCT)
has been used to detect the presence of venous thrombus in experimental models but has yet to be used in a
quantitative manner. In this study, we investigate the use of contrast-enhanced microCT for the longitudinal as-
sessment of experimental venous thrombus resolution.
Materials and methods: Thrombi induced by stenosis of the inferior vena cava in mice were imaged by contrast-
enhanced microCT at 1, 7 and 14 days post-induction (n= 18). Thrombus volumes were determined longitudi-
nally by segmentation and 3D volume reconstruction of microCT scans and by standard end-point histological
analysis at day 14. An additional group of thrombi were analysed solely by histology at 1, 7 and 14 days post-
induction (n = 15).
Results: IVC resident thrombuswas readily detectable by contrast-enhancedmicroCT.MicroCT-derivedmeasure-
ments of thrombus volume correlated well with time-matched histological analyses (ICC = 0.75, P b 0.01).
Thrombus volumesmeasured bymicroCTwere signiﬁcantly greater than those derived fromhistological analysis
(P b 0.001). Intra- and inter-observer analyses were highly correlated (ICC = 0.99 and 0.91 respectively, P b
0.0001). Further histological analysis revealed noticeable levels of contrast agent extravasation into the thrombus
that was associated with the presence of neovascular channels, macrophages and intracellular iron deposits.
Conclusion: Contrast-enhanced microCT represents a reliable and reproducible method for the longitudinal as-
sessment of venous thrombus resolution providing powerful paired data.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Experimental models enable the cellular and molecular mechanisms
that regulate the formation and resolution of venous thrombi to be stud-
ied and have afforded considerable insight into themolecular and cellular
mediators of these processes [1–3]. However, previous studies have relied
largely on end-point analysis of thrombus weight or ‘size’, or a combina-
tion of histology and image analysis of sections taken through the throm-
bus. Advances in imaging techniques have facilitated the in vivo
longitudinal measurement of thrombus, with magnetic resonance imag-
ing (MRI) using a clinical 3 T scanner for determination of thrombusascular Surgery, Cardiovascular
stminster Bridge Road, London
. This is an open access article undervolume in the experimental setting being recently reported [4,5]. MRI ac-
curately quantiﬁes thrombus size inmurinemodels of venous thrombosis
with high resolution, but access to these scanners is limited because of the
cost of this imaging modality. High frequency ultrasound has also been
used to study experimental models of venous thrombosis, but although
affordable requires a high degree of technical skill and so far only provides
two-dimensional imaging of the thrombus [6,7].
Contrast-enhanced computed tomography (CT) has been used to
demonstrate the presence of thrombus in man. Technological advances
in the ﬁeld of CT have facilitated the development of high-resolution
micro-computed tomography (microCT) imaging platforms suitable
for pre-clinical use [8]. The availability of microCT facilities has in-
creased considerably in the past decade and represents an affordable
and readily accessible methodology for pre-clinical imaging. MicroCT
has beenused extensively in the study ofmurinemodels of cardiovascu-
lar pathologies including critical limb ischaemia, abdominal aorticthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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lature in these pathologies requires intravenous administration of high
molecularweight blood-pool contrast agents, similar to CT angiography.
This imaging modality has also been used to identify the presence of
thrombus in a murine model of inferior vena cava (IVC) thrombosis
[3], however, a detailed characterisation for the longitudinal assessment
of thrombus resolution has yet to be reported. The aim of the present
study was to assess the applicability of contrast-enhanced microCT for
longitudinal measurement of thrombus resolution.
2. Materials and methods
2.1. St. Thomas' model of venous thrombosis
Thrombi were induced in the inferior vena cava (IVC) of 8–10week-
oldmale Balb/cmice as previously described [12]. Brieﬂy, amidline lap-
arotomy was carried out under general anaesthesia and sharp dissec-
tion used to separate the IVC from the aorta inferior to the left renal
vein. A piece of 4–0 mersilk suture (Ethicon, USA) was slung around
the IVC and tied onto a piece of 5–0 prolene suture (Ethicon, USA) laid
along the vessel which was then removed to generate a 90% stenosis
of the inferior vena cava. A neurovascular clip (Fine Scientiﬁc Tools,
Germany) was applied to the infra-renal segment of the IVC to induce
endothelial dysfunction. All procedures were carried out in accordance
with the UK Animals (Scientiﬁc Procedures) Act, 1986.
2.2. MicroCT
Mice were anaesthetised under 3% isoﬂurane at an oxygen ﬂow rate
of 1 l/min. Aurovist 15 nmnanogold (nAu) contrast agent (Nanoprobes,
USA, 200 mg/ml nAu) was diluted with saline to a concentration ofFig. 1. Imaging of IVC thrombi by contrast-enhanced microCT. A representative day 1 thrombu
(C) planes (scale bar 2 mm). Segmentation of the scan allow for reconstruction of 3D volume r
stenosis (S) and the thrombus (T).50mg/ml nAu. A 200 μl bolus of contrast agent was administered by in-
travenous injection into the tail vein giving a nAu dose of 10mg/mouse.
Contrast was allowed to circulate for 5 min prior to commencement of
the scan.
A nanoScan PET/CT 8W (Mediso Ltd., Hungary) was used to image
the thrombosed IVC. The mouse was placed on the scanner bed in the
prone position and a pressure transducer placed to measure respiration
rate. An initial scout view was obtained to allow speciﬁcation of the
anatomical limits of the high-resolution scan. A high-resolution scan
(maximum zoom, 360 projections, pitch 1, 45 kVP, 1000 ms exposure)
was completed taking approximately 20 min.
2.3. Image reconstruction
Scans were reconstructed using VivoQuant software (v1.22, Invicro,
USA) with a voxel size of 65 μm. Reconstructed scans were segmented
and analysed using ITKsnap software (v2.4, Open Source) [13]. Image
contrast was adjusted linearly to provide optimal parameters for
subsequent analysis. Thrombi were reconstructed in 3D using a semi-
automatic volumetric bubble propagation systemwith a balloon expan-
sion force of 1.00 and a curvature termof 0.20.Manual corrections to the
segmentation were made using the free-hand tool. When the segmen-
tation was complete a 3D renderedmesh of the thrombus was generat-
ed and thrombus volume recorded. A representative example of
segmentation of the thrombus from surrounding tissue has been pro-
vided in supplementary material (Fig. S1).
2.4. Histology
The thrombosed IVCwas excised from the site of stenosis to the iliac
bifurcation at 1, 7 and 14 days post-induction. Samples were ﬁxed ins imaged by contrast-enhanced microCT shown in transverse (A), sagittal (B) and coronal
enders (D–F). Images have been annotated with the position of the aorta (Ao), the site of
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cessor (Leica, Germany). 5 μm parafﬁn sections were cut at 500 μm in-
tervals throughout the length of the thrombus. Haematoxylin and
eosin (H&E) staining was used to visualise the thrombus within the
IVC as previously described [12]. Perls's stainingwas used to identify in-
tracellular iron deposits in thrombus sections by incubation with a
2%(w/v) potassium ferrocyanide in 2%(v/v) hydrochloric acid solution
for 20 min, followed by a distilled water wash and counterstaining for
5 min with Nuclear Fast Red (Vector Laboratories, UK). All sections
were dehydrated and mounted in DPX medium (Sigma, USA).
2.5. Immunohistochemistry
Macrophages and neovascular channels were localised in the throm-
bus by immunohistochemical localisation of Mac2 (galectin3) and CD31Fig. 2. Visualisation of the thrombus by histology and microCT. Thrombus was imaged at days
Representative transverse slices demonstrate the presence of thrombus in the IVC lumen (scale
(scale bar 200 μm). (J) Thrombus volume of time-matched samples determinedbymicroCT (bla
similar temporal changes in thrombus volume (one-wayANOVA, P b 0.0001). (K)Measurement
0.01), however, (L) corresponding Bland–Altman demonstrated a marked bias in absolute thro
n = 18 mice).expression respectively, as previously described [12]. In brief, sections
were dewaxed in xylene and rehydrated through graded alcohols. Heat-
mediated antigen retrieval was performed in citrate buffer (pH 6). Sec-
tions were blocked in serum-free protein solution (Dako, UK) prior to
incubation with either rat anti-mouse Mac2 (Biolegend, UK) or CD31
(Abcam, UK) for 1 h at room temperature. Sections were incubated
with appropriate biotinylated secondary antibodies for 45 min at room
temperature. Signal ampliﬁcation was achieved by incubation with
extravidin–peroxidase conjugates (Sigma, USA) for 1 h at room tempera-
ture (Mac2) orwith X-cell Plus HRP polymer (Menarini, UK) for 30min at
room temperature (CD31). Speciﬁc antigen–antibody conjugates were
visualised with either NovaRed or Vector SG (Vector Laboratories, UK)
chromagen substrates. Sections were counterstained with Mayer's
haemalum (ClinTech, UK) or Nuclear Fast Red (Vector Laboratories, UK),
dehydrated and mounted in DPX medium.1, 7 and 14 post-induction by contrast-enhanced microCT (n = 6 per timepoint). (A–C)
bar 2 mm), (D–F) corresponding with time-matched H&E stained thrombus micrographs
ck bars, n=6 per timepoint) and histology (white bars, n=5 per timepoint) demonstrate
s of thrombus volumebymicroCT and histologywere positively correlated (ICC=0.75, P b
mbus volume (M) more readily appreciated by paired analysis (Wilcoxon test, P b 0.001,
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H&E stained thrombus sections were imaged using a QICAM camera
(Q Imaging, Canada) attached to a brightﬁeld microscope (Leica DMRB,
Leica, Germany). Thrombus cross-sectional areaswere calculated by anal-
ysis of micrographs using Image Pro Plus software (MediaCybernetics,
UK) as previously described [12].
2.7. Statistics
Differences in thrombus volume over time, measured by histology
and microCT, were assessed by appropriate paired and unpaired one-
way analysis of variance (ANOVA) with differences between individual
time-points determined using Bonferroni's post-hoc tests. Endpoint
analysis of thrombus volume, as determined by both microCT and
histology, was assessed byWilcoxon's test. Relationships betweenmea-
surements of thrombus volume were examined by intra-class correla-
tion with data represented graphically using linear regression and
Bland–Altman plots. Spearman's correlation was used to investigate
the relationship between contrast extravasation and thrombus organi-
sation. Data is represented either as individual data points or mean ±
standard error.
3. Results
IVC resident thrombus was visualised in situ by contrast-enhanced
microCT. Thrombus presented as a hypo-perfused region distal to theFig. 3. Intra- and inter-observer variability of thrombus volume measurements bymicroCT. The
intra- and inter-observer analyses of thrombi imaged at days 1, 7 and 14 post-induction (n =
0.0001) (B) with no apparent bias between datasets (Bland–Altman). (C) Inter-observer me
bias in mean thrombus volume was apparent (Bland–Altman).site of stenosis (Fig. 1A–C). The presence of a perfusion defect in the
IVC lumen enabled segmentation of the thrombus from surrounding tis-
sue and subsequent reconstruction of 3D volume renders of the throm-
bus and surrounding vascular features (Fig. 1D–F).
At day 1 post-induction the thrombus was largely occlusive with
small regions of perfused lumen evident (Fig. 2A). At day 7 post-
induction a small amount of luminal recanalisation was apparent (Fig.
2B) although the majority of thrombi remained occlusive at some
point along the length. By day 14 post-induction marked recanalisation
of the vein lumen was noted (Fig. 2C) indicative of extensive remodel-
ling of the thrombus. This pattern of vein lumen recanalisation is consis-
tentwith histological analyses of time-point-matched samples (Fig. 2D–
F). Generation of 3D volume renders of the thrombus revealed that
whilst the acute day 1 thrombus appeared largely cylindrical, the resolv-
ing thrombus at day 7 and particularly at day 14 was heterogeneous
with respect to cross-sectional area (Fig. 2G–I). Thismatcheswith histo-
logical observations of thrombus cross-sectional area (Fig. S2, Supple-
mentary material).
Similar temporal changes in thrombus resolution were observed by
both contrast-enhanced microCT and histology with thrombus volume
signiﬁcantly reduced at day 14 post-induction compared to days 1 and
7 (P b 0.0001, Fig. 2J). Paired analysis of thrombus volume at day 14
demonstrated a strong positive correlation betweenmicroCT and histo-
logical measurements (ICC = 0.75, P b 0.01, Fig. 2K). Differences in ab-
solute thrombus volume were, however, apparent between the two
techniques. Bland–Altman analysis and comparison of paired measure-
ments of day 14 thrombi revealed amarkedly higher thrombus volumesreliability and reproducibility of thrombus volumemeasurements were assessed by both
6 mice per timepoint). (A) Intra-observer measurements correlated well (ICC = 0.99, P b
asurements were also well correlated (ICC = 0.91, P b 0.0001), however, (D) a marked
Fig. 4. Aurovist contrast agent extravasation. Aurovist contrast extravasation (dark staining) was observed in (A) H&E stained sections of day 14 thrombi. Contrast extravasation occurred
in highly organised regions of the thrombus rich in (B) Mac-2 positive macrophages and (C) CD31 positive neovascular channels (arrow heads) and (D) cellular iron deposits (scale bar
40 μm). The area of thrombus containing Aurovist correlated with (E) macrophage content (r = 0.41, P b 0.01), (F) neovascularisation (r = 0.60, P b 0.0001) and (G) iron deposits (r =
0.78, P b 0.0001), Spearman's rank n = 38 sections per group.
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analysis, which consistently and signiﬁcantly underestimate thrombus
volume (P b 0.001, Fig. 2M).
Variability in measurement of thrombus volume by microCT was
compared after either multiple measurements by a single observer
(intra-observer) or after measurements by multiple observers (inter-
observer). Intra-observer measurements of thrombus volume showed
a strong positive correlation (ICC = 0.99, P b 0.0001, Fig. 3A), with the
corresponding Bland–Altman plot demonstrating negligible bias (Fig.
3B). Inter-observer measurements also showed a strong positive corre-
lation (ICC= 0.91, P b 0.0001, Fig. 3C), although Bland–Altman analysis
showed a bias between measurements (~2 mm3) that appeared to in-
crease with size of the thrombus (Fig. 3D).
Histological examination of thrombi imaged longitudinally by
microCT and harvested at 14 days post-induction, revealed dense
black regions of extravasated contrast-agent in the thrombus periphery
in H&E stained sections (Fig. 4A). Contrast-agent extravasation correlat-
ed with thrombusMac2macrophage content (r= 0.41, P b 0.01, Fig. 4B
and E), the extent of CD31 positive neovascular channels (r = 0.60, P b
0.0001, Fig. 4C and F) and iron deposits localised by Perl's staining (r =
0.78, P b 0.0001, Fig. 4D and G).
4. Discussion
Contrast-enhanced microCT provides a rapid, reliable and sensitive
imaging modality for the longitudinal measurement of thrombus
volume in an established model of thrombosis [1]. Contrast-enhanced
microCTwas successful in delineating the thrombus from the surround-
ing tissue in all scans with a typical scan time of approximately 20 min.
The imaging protocol used was well tolerated with no adverse effects
associatedwith either repeated contrast injection or themicroCT proto-
col used.
Contrast-enhanced microCT identiﬁes thrombus as a perfusion
defect within the vessel lumen. Consistent with previous studies,
acute thrombi, such as at day 1 post-induction, were largely occlusivein nature [5]. Contrast agent was observed in proximal and distal seg-
ments of acute thrombi at day 1 post-induction. This signal may be at-
tributed to small regions of perfused IVC lumen or alternatively
extravasation of contrast agent into the vessel wall. The limited amount
of contrast-enhancement between the thrombus and the vein wall at
acute time-points made accurate segmentation challenging. This was
overcome by registration with anatomical structures surrounding the
thrombus including: the site of stenosis, aorta and distal segment of
the IVC.
The dynamics of thrombus resolution in this study were broadly
consistent with previous reports using the same model [14]. Com-
parison of measurements taken by microCT and histology show sim-
ilar temporal changes in thrombus volume during resolution. Both
measures demonstrated that thrombus volume was similar between
days 1 and 7 post-induction, but signiﬁcantly reduced between days
7 and 14. Direct comparison of paired microCT and histology mea-
surements at day 14 revealed a strong positive correlation, albeit
thrombus volumes determined by histology were consistently
smaller than those values obtained by microCT. A possible reason
for the observed differences in thrombus size measured by the two
techniques is the occurrence of tissue shrinkage during processing
for histological analysis [15].
Intra- and inter-observer variabilitywere assessed in order to exam-
ine the reliability of image analysis of themicroCT scans. The strong pos-
itive correlation between intra-observer measurements indicated that
the thrombus could be segmented in a reproducible manner by an indi-
vidual observer. However, although inter-observer measurements
showed a strong positive correlation, there may be bias in the segmen-
tation of the thrombus by different observers. To limit the effect of ob-
server dependent bias it may be advantageous for individual data sets
to be analysed by a single observer in a blinded manner.
The nAu contrast agent Aurovist used in this study provides a high
level of contrast enhancement compared to alternative agents such as
iomeprol and ExiTron nano12000 [16]. This approach allows for rela-
tively low volumes of contrast agent to be administered. Good blood
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of a single bolus of contrast-agent rather than constant infusion used
with traditional ionidated agents [16]. Aurovist is cleared by the kid-
neys, in a manner similar to iodinated agents, but this is not associated
with the same degree of nephrotoxicity [17]. These characteristicsmake
Aurovist a suitable contrast agent for longitudinal imaging of the
vasculature.
It was not unexpected to ﬁndAurovist extravasating into the throm-
bus given the size of these particles (~15 nm). Histological analysis of
thrombi conﬁrmed the presence of the Aurovist in highly organised re-
gions of the thrombus with extensive neovascularisation and rich in
macrophage/haemosiderin-containing cells. This could have been as a
result of vascular hyperpermeability similar to that observed in tumour
neovessels [18]. Subsequent uptake of Aurovist particles by thrombus-
resident macrophages may have occurred, as demonstrated by a num-
ber of in vitro studies [19,20]. Extravasation of contrast-agent is most
likely to have taken place after day 7, the time-point at which
neovascular channel formation and macrophage ingress are ﬁrst ob-
served [12].
With respect to clinical applicability, contrast-enhanced CT is not
commonly used in the diagnosis of DVT. Instead, non-contrast duplex
ultrasonography is currently considered the gold-standard imaging
technique for diagnosis [21]. The development of clinical 3D ultrasound
devices has enabled longitudinal, quantitativemeasurements of throm-
bus volume and represents a complementary technique for assessment
of thrombus resolution in man [22].
To conclude, the data provided in this study supports the utility of
contrast-enhanced microCT in longitudinal measurement of thrombus
in experimental models. This imaging modality provides powerful,
paired in vivo data of thrombus resolution, potentially reducing the
number of animals required for experimentation.
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